ALKEM — Alkem Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Alkem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	106,342	115,993	126,676	129,645	147,123
Cost of Revenue
Gross Profit	62,074	65,049	74,769	79,508	94,150
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	88,627	103,201	106,811	107,967	121,893
Operating Profit	17,715	12,792	19,865	21,678	25,230
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	18,443	13,048	20,231	25,264	28,689
Provision for Income Taxes
Net Income After Taxes	16,803	10,068	18,115	22,154	23,512
Minority Interest
Net Income Before Extraordinary Items
Net Income	16,456	9,842	17,958	21,655	23,018
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	16,456	9,842	17,958	21,655	23,018
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	138	89.9	150	182	205
Dividends per Share
Special Dividends per Share